Sufentanil Citrate is Used for managing acute pain. It was first introduced by Rising Pharma Holdings Inc in its drug Sufenta Preservative Free on May 4, 1984. Another drug containing Sufentanil Citrate is Dsuvia. 5 different companies have introduced drugs containing Sufentanil Citrate.

Sufentanil Citrate Patents

Given below is the list of patents protecting Sufentanil Citrate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Dsuvia	US11672738	Apparatus and methods for dispensing oral transmucosal dosage forms	Feb 02, 2038	Vertical Pharms
Dsuvia	US8945592	Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same	Jul 29, 2031	Vertical Pharms
Dsuvia	US8202535	Small-volume oral transmucosal dosage forms	Oct 22, 2030	Vertical Pharms
Dsuvia	US8865743	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Oct 22, 2030	Vertical Pharms
Dsuvia	US10896751	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar 16, 2030	Vertical Pharms
Dsuvia	US11676691	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar 16, 2030	Vertical Pharms
Dsuvia	US12033733	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar 16, 2030	Vertical Pharms
Dsuvia	US8574189	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar 16, 2030	Vertical Pharms
Dsuvia	US10245228	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US10342762	Small-volume oral transmucosal dosage forms	Jan 05, 2027	Vertical Pharms
Dsuvia	US10507180	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US8226978	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US8231900	Small-volume oral transmucosal dosage	Jan 05, 2027	Vertical Pharms
Dsuvia	US8252328	Bioadhesive drug formulations for oral transmucosal delivery	Jan 05, 2027	Vertical Pharms
Dsuvia	US8252329	Bioadhesive drug formulations for oral transmucosal delivery	Jan 05, 2027	Vertical Pharms
Dsuvia	US8535714	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US8778393	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US8778394	Small-volume oral transmucosal dosage forms	Jan 05, 2027	Vertical Pharms
Dsuvia	US8865211	Bioadhesive drug formulations for oral transmucosal delivery	Jan 05, 2027	Vertical Pharms
Dsuvia	US9320710	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms
Dsuvia	US9744129	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan 05, 2027	Vertical Pharms

Add above patents to watchlist

Sufentanil Citrate's Family Patents

Full family tree

Sufentanil Citrate Generic API Manufacturers

Several generic applications have been filed for Sufentanil Citrate. The first generic version for Sufentanil Citrate was by Watson Laboratories Inc and was approved on Dec 15, 1995. And the latest generic version is by Hospira Inc and was approved on Dec 11, 1996.

Given below is the list of companies who have filed for Sufentanil Citrate generic, along with the locations of their manufacturing plants worldwide.